Stockscreener 앱 받기
249.19
1.56%
3.83
시간 외 거래:
249.00
-0.19
-0.08%
전일 마감가:
$245.36
열려 있는:
$244.72
하루 거래량:
848.69K
Relative Volume:
0.83
시가총액:
$36.37B
수익:
$5.26B
순이익/손실:
$1.44B
주가수익비율:
25.50
EPS:
9.7713
순현금흐름:
$1.76B
1주 성능:
+2.51%
1개월 성능:
-2.87%
6개월 성능:
-3.02%
1년 성능:
+6.00%
1일 변동 폭
$243.50
$250.15
1주일 범위
$240.00
$250.15
52주 변동 폭
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
명칭
Resmed Inc
전화
(858) 746-2400
주소
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
RMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
249.19 | 35.81B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
ISRG
Intuitive Surgical Inc
|
592.85 | 200.78B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
205.36 | 56.69B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
81.81 | 39.62B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
39.77 | 30.70B | 27.43B | 1.27B | 1.01B | 1.5829 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-16 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-09-18 | 개시 | Citigroup | Buy |
| 2025-09-02 | 업그레이드 | CLSA | Hold → Outperform |
| 2025-07-15 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | 개시 | Morgan Stanley | Overweight |
| 2025-01-16 | 개시 | Goldman | Buy |
| 2025-01-10 | 개시 | Piper Sandler | Neutral |
| 2024-12-13 | 개시 | Stifel | Hold |
| 2024-09-24 | 개시 | Robert W. Baird | Outperform |
| 2024-09-18 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | 다운그레이드 | Needham | Buy → Hold |
| 2024-06-25 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-06-24 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-09-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | 업그레이드 | Needham | Hold → Buy |
| 2023-09-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-08-01 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 개시 | UBS | Buy |
| 2023-04-14 | 개시 | Mizuho | Buy |
| 2023-01-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-10-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-20 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-09-08 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-08-15 | 다운그레이드 | CLSA | Buy → Outperform |
| 2022-08-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-08-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-01-31 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-01-28 | 업그레이드 | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-01-13 | 업그레이드 | CLSA | Outperform → Buy |
| 2022-01-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | 업그레이드 | Macquarie | Neutral → Outperform |
| 2021-10-22 | 업그레이드 | CLSA | Underperform → Outperform |
| 2021-08-02 | 다운그레이드 | CLSA | Outperform → Sell |
| 2021-08-02 | 다운그레이드 | Needham | Buy → Hold |
| 2021-07-28 | 업그레이드 | Jefferies | Underperform → Hold |
| 2021-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 개시 | RBC Capital Mkts | Underperform |
| 2021-06-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-06-22 | 업그레이드 | Macquarie | Neutral → Outperform |
| 2021-06-22 | 개시 | Robert W. Baird | Neutral |
| 2021-06-21 | 재확인 | Needham | Buy |
| 2021-06-16 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-06-09 | 업그레이드 | CLSA | Sell → Outperform |
| 2021-05-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-04-30 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-03-16 | 업그레이드 | Needham | Hold → Buy |
| 2020-11-02 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-30 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2020-10-27 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-01 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 개시 | CLSA | Underperform |
| 2020-01-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Perform |
| 2019-11-22 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | 업그레이드 | UBS | Neutral → Buy |
| 2019-07-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-05-06 | 업그레이드 | UBS | Neutral → Buy |
| 2019-04-18 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-01-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2019-01-25 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-10-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 개시 | Goldman | Buy |
모두보기
Resmed Inc 주식(RMD)의 최신 뉴스
Global Sleep Tech Devices Market Poised for Strong Growth at a CAGR of ~17% by 2032, Driven by Rising Sleep Disorder Prevalence | DelveInsight - GlobeNewswire Inc.
Asset Management One Co. Ltd. Raises Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Updates CDI and Share Structure for December 2025 - TipRanks
Insider Sell: Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD) - GuruFocus
ResMed Officer Brett Sandercock Discloses Planned Sale of 1,000 Shares Under Trading Plan - TipRanks
ResMed (NYSE:RMD) General Counsel Michael Rider Sells 50 Shares - MarketBeat
ResMed Q2 2026 Earnings Preview: EPS Growth Forecast & Analyst Rating | BarchartNews and Statistics - IndexBox
ResMed Inc. $RMD Shares Sold by TriaGen Wealth Management LLC - MarketBeat
What You Need to Know Ahead of ResMed's Earnings Release - Barchart.com
ResMed Inc.: How a Sleep-Tech Powerhouse Is Turning Data, Devices and Chronic Care Into a Platform P - AD HOC NEWS
Geopolitics Watch: Is ResMed Inc Common Stock RMEA stock overpriced at current multiplesWeekly Profit Summary & Weekly Return Optimization Plans - moha.gov.vn
ResMed Inc Reports Changes in CHESS Depositary Interests and Securities - MSN
ResMed Inc. (NYSE:RMD) is favoured by institutional owners who hold 69% of the company - simplywall.st
ResMed Inc. $RMD Shares Sold by Inspire Investing LLC - MarketBeat
Here's What ResMed's (NYSE:RMD) Strong Returns On Capital Mean - Yahoo Finance
ResMed Inc. Reports Changes in Beneficial Ownership - MSN
The Truth About ResMed Inc: Is This Sleep Tech Stock Quietly Going Viral? - AD HOC NEWS
ResMed (RMD) Product Pipeline Analysis Report 2025 – ResearchAndMarkets.com - The AI Journal
ResMed (RMD) Product Pipeline Analysis Report 2025ResearchAndMarkets.com - Bluefield Daily Telegraph
Is ResMed CDI (ASX:RMD) Still Shaping Value For Investors? - Kalkine Media
Ethic Inc. Raises Stock Holdings in ResMed Inc. $RMD - MarketBeat
Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance
BSX vs. RMD: Which Medical Device Stock Is the Stronger Play Now? - The Globe and Mail
3 Stocks Likely to Gain From Rising HSA Contribution & Medicare Premium - TradingView — Track All Markets
ResMed Inc announces proposed sale of securities by director - MSN
The Truth About ResMed Inc.: Is This Sleep Tech Stock the Next Viral Gamechanger or Just Hype? - AD HOC NEWS
ResMed Stock Breathes Easier as Sleep-Apnea Giant Outpaces the Market - AD HOC NEWS
ResMed Inc. $RMD Stock Holdings Raised by Pacer Advisors Inc. - MarketBeat
Why analysts maintain buy rating on ResMed Inc. (RME) stockGlobal Market Influence & Big Gains Small Capital - bollywoodhelpline.com
ResMed Officer Plans Further Share Sale Under Rule 144 - MSN
ResMed Inc. (NYSE:RMD) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Voya Investment Management LLC Has $8.97 Million Position in ResMed Inc. $RMD - MarketBeat
Swedbank AB Increases Stock Position in ResMed Inc. $RMD - MarketBeat
Is ResMed stock underperforming the S&P 500? - MSN
Why ResMed (RMD) is a Top Growth Stock for the Long-Term - Yahoo Finance
OLD National Bancorp IN Increases Stock Holdings in ResMed Inc. $RMD - MarketBeat
Patton Fund Management Inc. Has $265,000 Stock Holdings in ResMed Inc. $RMD - MarketBeat
Confluence Investment Management LLC Sells 4,405 Shares of ResMed Inc. $RMD - MarketBeat
Thrivent Financial for Lutherans Acquires 5,212 Shares of ResMed Inc. $RMD - MarketBeat
The Bull Case For ResMed (RMD) Could Change Following FDA-Cleared AI Smart Comfort CPAP Feature - Sahm
Texas Permanent School Fund Corp Sells 5,560 Shares of ResMed Inc. $RMD - MarketBeat
Assenagon Asset Management S.A. Sells 5,635 Shares of ResMed Inc. $RMD - MarketBeat
Will ResMed Inc. (Common Stock) (RMEA) stock beat revenue estimatesPortfolio Performance Report & Intraday High Probability Alerts - ulpravda.ru
Technical Analysis: Will ResMed Inc. stock gain from strong economyTrend Reversal & Weekly High Return Stock Forecasts - ulpravda.ru
Is ResMed Inc. stock attractive for long term wealth buildingJuly 2025 Price Swings & Real-Time Volume Analysis - DonanımHaber
Will ResMed Inc. stock deliver better than expected guidanceJuly 2025 Movers & Long Hold Capital Preservation Tips - DonanımHaber
Resmed Inc Officer Plans Sale of Common Stock - MSN
Will ResMed Inc. stock attract more institutional investorsMarket Volume Report & Real-Time Volume Triggers - Улправда
Will ResMed Inc. stock benefit from automationQuarterly Trade Review & Growth-Oriented Investment Plans - DonanımHaber
Why ResMed Inc. stock is a value investor pickJuly 2025 Short Interest & Smart Money Movement Tracker - Улправда
ResMed Inc. $RMD Shares Acquired by Addenda Capital Inc. - MarketBeat
Resmed Inc (RMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.44%
자본화:
|
볼륨(24시간):